Skip Navigation LinksHome > December 1980 - Volume 7 - Issue 6 > 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced Pulmonar...
Clinical and scientific communications: PDF Only

1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced Pulmonary Fibrosis.

Selker, Robert G. M.D.; Jacobs, Samuel A. M.D.; Moore, Pearl B. M.N.; Wald, Michael M.D.; Fisher, Edwin R.; Cohen, Manfred M.D. M.D.; Bellot, Peter M.D.

Collapse Box


: Clinical data are presented on 14 patients undergoing BCNU therapy for a primary intracranial glioma (11 biopsied, 3 suspected) in whom pulmonary fibrosis developed as a consequence of the therapy. Pulmonary diffusion abnormalities, dry hacking cough, and chest x-ray changes herald the onset of the process. Microscopic evaluation of lung specimens revealed a wide spectrum of change including hyaline membrane formation, alveolar septal thickening, interstitial fibrosis, and granuloma formation. It is concluded that BCNU causes pulmonary fibrosis that is primarily but not necessarily doserelated and may not be reversible. (Neurosurgery, 7: 560-565, 1980)

Copyright (C) by the Congress of Neurological Surgeons


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.